Search - tctmd.com

Displaying 401 - 420 of 1148

Sort: Relevancy | Date

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

News Daily News

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Michael O'Riordan

March 11, 2021

News Daily News

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

Michael O'Riordan

March 05, 2021

News Daily News

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Michael O'Riordan

March 04, 2021

News Daily News

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

Michael O'Riordan

March 03, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March Week 1

Todd Neale

March 01, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Daily News

High Glycemic Index Diets Linked to CVD and Mortality

Michael O'Riordan

February 24, 2021

News Daily News

CV Complications of Malaria Rare but Portend Poor Prognosis

Michael O'Riordan

February 22, 2021

News Daily News

Hospitals Likely Miscount True STEMIs, Analysis Suggests

Michael O'Riordan

February 19, 2021

News Daily News

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Michael O'Riordan

February 19, 2021

News Daily News

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

Michael O'Riordan

February 15, 2021

News Daily News

FDA Issues Class I Recall for Emblem S-ICD Over Electrode Fractures

Michael O'Riordan

February 12, 2021

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

FDA Approves Evinacumab for Rare Homozygous FH

Michael O'Riordan

February 11, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

News Daily News

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

Michael O'Riordan

February 05, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

Advertisement

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention

Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19

MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost

Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

COVID-19: TCTMD’s Daily Dispatch for March Week 1

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

High Glycemic Index Diets Linked to CVD and Mortality

CV Complications of Malaria Rare but Portend Poor Prognosis

Hospitals Likely Miscount True STEMIs, Analysis Suggests

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients

FDA Issues Class I Recall for Emblem S-ICD Over Electrode Fractures

Site Investigators Missed Clinical Events in GLOBAL LEADERS

FDA Approves Evinacumab for Rare Homozygous FH

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Large Meta-analysis Confirms Survival, Bleeding Benefits With Radial Access

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content